Breaking News

Cambrex Expands Process Development at Edinburgh Facility

Doubles current footprint to 15,000 sq. ft., adding lab space to accommodate 40 more scientists

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex Corp. is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland, doubling the current footprint to 15,000 sq. ft. The site currently has 50 employees and the expansion will add lab space to accommodate as many as 40 more scientists, with the potential for further growth in the future. Fit out is expected to begin in late August 2019 and completed by the end of the year.   The Edinburgh site provides solid form development services for...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters